Cannabidiol for Reduction of Brain Neuroinflammation

Clinical trial NCT05066308 · RECRUITING

Trial details

NCT number: NCT05066308
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Back Pain Depressive Symptoms

Start date: 2022-01-04
Primary completion: 2026-09-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.